Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of quality, efficacy and safety to an innovative reference medicinal product.According to the report, one driver that will lead to the growth of this market is the rise in number of patent expiries.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Monoclonal antibodies (mAbs) Biosimilars market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Monoclonal antibodies (mAbs) Biosimilars market. Detailed analysis of key players, along with key growth strategies adopted by Monoclonal antibodies (mAbs) Biosimilars industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
3SBio
Dr Reddy's Laboratories
Allergan
Celltrion
Biocon
Accord Healthcare
Amega Biotech
Hospira
Others
AET Biotech
By Type:
Erythropoietin (EPO)
Human Growth Hormone (HGH)
Granulocyte- Colony Stimulating Factor (G-CSF)
Monoclonal Antibody (mAb)
Insulin
Interferon (IFN)
AET Biotech
By End-User:
Anti-Cancer
Anti-Inflammatory/Autoimmune
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Monoclonal antibodies (mAbs) Biosimilars Market
-
1.3 Market Segment by Type
-
1.3.1 USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Erythropoietin (EPO) from 2016 to 2027
-
1.3.2 USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Human Growth Hormone (HGH) from 2016 to 2027
-
1.3.3 USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF) from 2016 to 2027
-
1.3.4 USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Monoclonal Antibody (mAb) from 2016 to 2027
-
1.3.5 USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Insulin from 2016 to 2027
-
1.3.6 USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Interferon (IFN) from 2016 to 2027
-
1.3.7 USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of AET Biotech from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Anti-Cancer from 2016 to 2027
-
1.4.2 USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Anti-Inflammatory/Autoimmune from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Monoclonal antibodies (mAbs) Biosimilars Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Monoclonal antibodies (mAbs) Biosimilars by Major Types
-
3.4.1 Market Size and Growth Rate of Erythropoietin (EPO)
-
3.4.2 Market Size and Growth Rate of Human Growth Hormone (HGH)
-
3.4.3 Market Size and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF)
-
3.4.4 Market Size and Growth Rate of Monoclonal Antibody (mAb)
-
3.4.5 Market Size and Growth Rate of Insulin
-
3.4.6 Market Size and Growth Rate of Interferon (IFN)
-
3.4.7 Market Size and Growth Rate of AET Biotech
4 Segmentation of Monoclonal antibodies (mAbs) Biosimilars Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Monoclonal antibodies (mAbs) Biosimilars by Major End-Users
-
4.4.1 Market Size and Growth Rate of Monoclonal antibodies (mAbs) Biosimilars in Anti-Cancer
-
4.4.2 Market Size and Growth Rate of Monoclonal antibodies (mAbs) Biosimilars in Anti-Inflammatory/Autoimmune
5 Market Analysis by Regions
-
5.1 USA Monoclonal antibodies (mAbs) Biosimilars Production Analysis by Regions
-
5.2 USA Monoclonal antibodies (mAbs) Biosimilars Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis
-
6.1 West USA Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major Types
-
6.2 West USA Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major End-Users
7 South USA Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis
-
7.1 South USA Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major Types
-
7.2 South USA Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major End-Users
8 Middle West USA Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis
-
8.1 Middle West USA Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major Types
-
8.2 Middle West USA Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major End-Users
9 Northeast USA Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis
-
9.1 Northeast USA Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major Types
-
9.2 Northeast USA Monoclonal antibodies (mAbs) Biosimilars Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 3SBio
-
10.1.1 3SBio Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Dr Reddy's Laboratories
-
10.2.1 Dr Reddy's Laboratories Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Allergan
-
10.3.1 Allergan Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Celltrion
-
10.4.1 Celltrion Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Biocon
-
10.5.1 Biocon Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Accord Healthcare
-
10.6.1 Accord Healthcare Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Amega Biotech
-
10.7.1 Amega Biotech Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Hospira
-
10.8.1 Hospira Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Others
-
10.9.1 Others Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 AET Biotech
-
10.10.1 AET Biotech Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Erythropoietin (EPO) from 2016 to 2027
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Human Growth Hormone (HGH) from 2016 to 2027
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF) from 2016 to 2027
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Monoclonal Antibody (mAb) from 2016 to 2027
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Insulin from 2016 to 2027
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Interferon (IFN) from 2016 to 2027
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of AET Biotech from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Anti-Cancer from 2016 to 2027
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Anti-Inflammatory/Autoimmune from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Monoclonal antibodies (mAbs) Biosimilars Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Monoclonal antibodies (mAbs) Biosimilars
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Monoclonal antibodies (mAbs) Biosimilars by Different Types from 2016 to 2027
-
Table Consumption Share of Monoclonal antibodies (mAbs) Biosimilars by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Erythropoietin (EPO)
-
Figure Market Size and Growth Rate of Human Growth Hormone (HGH)
-
Figure Market Size and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF)
-
Figure Market Size and Growth Rate of Monoclonal Antibody (mAb)
-
Figure Market Size and Growth Rate of Insulin
-
Figure Market Size and Growth Rate of Interferon (IFN)
-
Figure Market Size and Growth Rate of AET Biotech
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Monoclonal antibodies (mAbs) Biosimilars by Different End-Users from 2016 to 2027
-
Table Consumption Share of Monoclonal antibodies (mAbs) Biosimilars by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Anti-Cancer
-
Figure Market Size and Growth Rate of Anti-Inflammatory/Autoimmune
-
Table USA Monoclonal antibodies (mAbs) Biosimilars Production by Regions
-
Table USA Monoclonal antibodies (mAbs) Biosimilars Production Share by Regions
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Production Share by Regions in 2016
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Production Share by Regions in 2021
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Production Share by Regions in 2027
-
Table USA Monoclonal antibodies (mAbs) Biosimilars Consumption by Regions
-
Table USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Regions
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Regions in 2016
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Regions in 2021
-
Figure USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Regions in 2027
-
Table West USA Monoclonal antibodies (mAbs) Biosimilars Consumption by Types from 2016 to 2027
-
Table West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2016
-
Figure West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2021
-
Figure West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2027
-
Table West USA Monoclonal antibodies (mAbs) Biosimilars Consumption by End-Users from 2016 to 2027
-
Table West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2016
-
Figure West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2021
-
Figure West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2027
-
Table South USA Monoclonal antibodies (mAbs) Biosimilars Consumption by Types from 2016 to 2027
-
Table South USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure South USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2016
-
Figure South USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2021
-
Figure South USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2027
-
Table South USA Monoclonal antibodies (mAbs) Biosimilars Consumption by End-Users from 2016 to 2027
-
Table South USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2016
-
Figure South USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2021
-
Figure South USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2027
-
Table Middle West USA Monoclonal antibodies (mAbs) Biosimilars Consumption by Types from 2016 to 2027
-
Table Middle West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2016
-
Figure Middle West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2021
-
Figure Middle West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2027
-
Table Middle West USA Monoclonal antibodies (mAbs) Biosimilars Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2016
-
Figure Middle West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2021
-
Figure Middle West USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2027
-
Table Northeast USA Monoclonal antibodies (mAbs) Biosimilars Consumption by Types from 2016 to 2027
-
Table Northeast USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2016
-
Figure Northeast USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2021
-
Figure Northeast USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by Types in 2027
-
Table Northeast USA Monoclonal antibodies (mAbs) Biosimilars Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2016
-
Figure Northeast USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2021
-
Figure Northeast USA Monoclonal antibodies (mAbs) Biosimilars Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of 3SBio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3SBio
-
Figure Sales and Growth Rate Analysis of 3SBio
-
Figure Revenue and Market Share Analysis of 3SBio
-
Table Product and Service Introduction of 3SBio
-
Table Company Profile and Development Status of Dr Reddy's Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy's Laboratories
-
Figure Sales and Growth Rate Analysis of Dr Reddy's Laboratories
-
Figure Revenue and Market Share Analysis of Dr Reddy's Laboratories
-
Table Product and Service Introduction of Dr Reddy's Laboratories
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Celltrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion
-
Figure Sales and Growth Rate Analysis of Celltrion
-
Figure Revenue and Market Share Analysis of Celltrion
-
Table Product and Service Introduction of Celltrion
-
Table Company Profile and Development Status of Biocon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
-
Figure Sales and Growth Rate Analysis of Biocon
-
Figure Revenue and Market Share Analysis of Biocon
-
Table Product and Service Introduction of Biocon
-
Table Company Profile and Development Status of Accord Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Accord Healthcare
-
Figure Sales and Growth Rate Analysis of Accord Healthcare
-
Figure Revenue and Market Share Analysis of Accord Healthcare
-
Table Product and Service Introduction of Accord Healthcare
-
Table Company Profile and Development Status of Amega Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amega Biotech
-
Figure Sales and Growth Rate Analysis of Amega Biotech
-
Figure Revenue and Market Share Analysis of Amega Biotech
-
Table Product and Service Introduction of Amega Biotech
-
Table Company Profile and Development Status of Hospira
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira
-
Figure Sales and Growth Rate Analysis of Hospira
-
Figure Revenue and Market Share Analysis of Hospira
-
Table Product and Service Introduction of Hospira
-
Table Company Profile and Development Status of Others
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Others
-
Figure Sales and Growth Rate Analysis of Others
-
Figure Revenue and Market Share Analysis of Others
-
Table Product and Service Introduction of Others
-
Table Company Profile and Development Status of AET Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AET Biotech
-
Figure Sales and Growth Rate Analysis of AET Biotech
-
Figure Revenue and Market Share Analysis of AET Biotech
-
Table Product and Service Introduction of AET Biotech
-
